| Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment CE Quevedo, A Cruz-Migoni, N Bery, A Miller, T Tanaka, D Petch, ... Nature communications 9 (1), 3169, 2018 | 124 | 2018 |
| Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds A Cruz-Migoni, P Canning, CE Quevedo, CJR Bataille, N Bery, A Miller, ... Proceedings of the National Academy of Sciences 116 (7), 2545-2550, 2019 | 122 | 2019 |
| A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription K Ewan, B Pająk, M Stubbs, H Todd, O Barbeau, C Quevedo, H Botfield, ... Cancer research 70 (14), 5963-5973, 2010 | 122 | 2010 |
| Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions N Bery, A Cruz-Migoni, CJR Bataille, CE Quevedo, H Tulmin, A Miller, ... Elife 7, e40515, 2018 | 60* | 2018 |
| Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family Bioorganic & Medicinal Chemistry 25 (9), 2657–2665, 2017 | 54 | 2017 |
| Thermal elimination of diethyldithiocarbamates and application in the synthesis of (±)-Ferrugine S Ahmed, LA Baker, RS Grainger, P Innocenti, CE Quevedo The Journal of Organic Chemistry 73 (20), 8116-8119, 2008 | 42 | 2008 |
| A Novel Color Change Mechanism for Breast Cancer Biomarker Detection: Naphthoquinones as Specific Ligands of Human Arylamine N-Acetyltransferase 1 N Laurieri, JE Egleton, A Varney, CC Thinnes, CE Quevedo, PT Seden, ... PLoS One 8 (8), e70600, 2013 | 21 | 2013 |
| Microwave-assisted synthesis of 2-aminonicotinic acids by reacting 2-chloronicotinic acid with amines CE Quevedo, V Bavetsias, E McDonald Tetrahedron Letters 50 (21), 2481-2483, 2009 | 19 | 2009 |
| Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein L Bao, C Hannon, A Cruz-Mignoni, D Ptchelkine, M Sun, A Miller, ... Scientific Reports 7 (1), 16869, 2017 | 8 | 2017 |
| Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family CE Quevedo, CJR Bataille, S Byrne, M Durbin, J Elkins, A Guillermo, ... Bioorganic & Medicinal Chemistry 28 (22), 115724, 2020 | 3 | 2020 |
| Compounds T Rabbitts, C Quevedo, C Abimael, S Phillips, PS Fallon, JN Dunn, ... US Patent 12,024,506, 2024 | | 2024 |
| Compounds useful in the treatment of disorders associated with mutant RAS T Rabbitts, C Quevedo, C Bataille US Patent 11,970,469, 2024 | | 2024 |
| Inhibitors of RAS-effector protein interactions T Rabbitts, C Quevedo, C Abimael, S Phillips, PS Fallon, A Hopkins, ... US Patent 11,724,999, 2023 | | 2023 |
| Compounds T Rabbitts, C QUEVEDO, C Abimael, S Philips, PS Fallon, JN DUNN, ... | | 2019 |
| WO 2019/145719 A1 CE Quevedo, TH Rabbitts, SEV Phillips, A Cruz WO Patent WO 2019/145719 A1, 2019 | | 2019 |
| WO 2019/145718 A1 CE Quevedo, TH Rabbitts, SEV Phillips, A Cruz WO Patent WO 2019/145718 A1, 2019 | | 2019 |
| Abstract LB-068: From intracellular antibody fragments to small molecule inhibitors of mutant KRAS CE Quevedo, A Cruz, H Tulmin, CJ Bataille, T Tanaka, D Petch, ... Cancer Research 77 (13_Supplement), LB-068-LB-068, 2017 | | 2017 |
| Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein. BLY Bao LeYuan, C Hannon, A Cruz-Mignoni, D Ptchelkine, ... | | 2017 |
| Substituted heterocyclic compounds and their use as PIM kinase inhibitors BS GB], DM GB], JA GB], MC GB], QC GB], LIUGU GB], SP GB], BC GB], ... GB Patent GB2,497,858, 2013 | | 2013 |
| A Novel Color Change Mechanism for Breast Cancer Biomarker Detection N Laurieri, JE Egleton, A Varney, CC Thinnes, CE Quevedo | | 2013 |
